Phase II study of alpha-interferon plus bleomycin in advanced non-small cell lung cancer.

Abstract

A synergistic effect between alpha-Interferon and Bleomycin has been recently shown in in vitro and in vivo experimental systems. Although active, Bleomycin and other antineoplastic drugs give low response rates in non-small cell lung cancer, but, like the other antineoplastic agents, responses are short-lived. We treated 13 patients with advanced non-small… (More)

Topics

  • Presentations referencing similar topics